BridgeMD
Intranasal dexmedetomidine sedation and analgesia during pediatric emergency room procedures
EU CTIS ID: 2024-518816-38-00
What this study is testing
Our objective is to determine if intranasal dexmedetomidine is a safe and effective sedative drug during small painful procedures in the pediatric emergency room.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Age 1-12 years
- Small procedure (e.g. i.v. cannulation or lumbar puncture)
- Presents at the Oulu University Hospital emergency room
You likely can't join if
- Allergy to dexmedetomidine or any supplementary elements of the dexmedetomidine-solution
- II or III degree AV-blockage without pacemaker
- Uncontrollable hypotension
- Stroke
- Critically ill patients who are admitted to the Pediatric Intensive Care Unit
- Patients with clear cardiac or respiratory dysfunction
See the full eligibility criteria
- Age 1-12 years
- Small procedure (e.g. i.v. cannulation or lumbar puncture)
- Presents at the Oulu University Hospital emergency room
- Allergy to dexmedetomidine or any supplementary elements of the dexmedetomidine-solution
- II or III degree AV-blockage without pacemaker
- Uncontrollable hypotension
- Stroke
- Critically ill patients who are admitted to the Pediatric Intensive Care Unit
- Patients with clear cardiac or respiratory dysfunction
- Lowered level of consciousness
- Patients with increased risk of apnoeic events due to neurologic or metabolic conditions or extreme obesity
- Prior participation to the current study
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.